IC
RLAY icon

IEQ Capital’s Relay Therapeutics RLAY Stock Holding History

IEQ Capital’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.37M Sell
126,829
-78,481
-38% -$1.14M 0.01% 739
2026
Q1 		$2.04M Buy
205,310
+43,025
+27% +$385K 0.01% 762
2025
Q4 		$1.37M Sell
162,285
-34,174
-17% -$244K ﹤0.01% 914
2025
Q3 		$1.03M Buy
196,459
+17,135
+10% +$65.3K ﹤0.01% 992
2025
Q2 		$620K Buy
179,324
+122,990
+218% +$366K ﹤0.01% 1062
2025
Q1 		$148K Buy
+56,334
New +$221K ﹤0.01% 1430

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

IEQ Capital's RLAY Position: Q2 2026 in Review

IEQ Capital reduced its Relay Therapeutics (RLAY) stake by 38% in Q2 2026, selling an estimated $1.14M and leaving 126,829 shares worth $2.37M. The position accounts for 0.01% of the portfolio, ranked #739.

IEQ Capital first reported a position in RLAY in Q1 2025 and has held it in 6 quarters since. 258 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • IEQ Capital held 126,829 shares of Relay Therapeutics worth $2.37M as of Q2 2026.
  • IEQ Capital sold 78,481 Relay Therapeutics shares in Q2 2026, an estimated $1.14M.
  • Relay Therapeutics made up 0.01% of IEQ Capital's portfolio in Q2 2026, its #739 holding.
  • IEQ Capital first reported a position in Relay Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • 258 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.